FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024069318> ?p ?o ?g. }

• W2024069318 endingPage "526" @default.
• W2024069318 startingPage "519" @default.
• W2024069318 abstract "The aim of this exploratory subgroup analysis of the fluorouracil, oxaliplatin, docetaxel (FLOT)65+ trial was to determine tolerability and feasibility of perioperative chemotherapy in elderly, potentially operable esophagogastric cancer patients.Patients aged ≥65 with locally advanced esophagogastric adenocarcinoma were randomized to perioperative chemotherapy consisting of four pre- and four postoperative cycles of infusional 5-FU, leucovorin, and oxaliplatin (FLO) without or with docetaxel 50 mg m(-)(2) (FLOT), every 2 weeks.Forty-four patients with a median age of 70 years were randomized and 43 patients started preoperative chemotherapy (FLO, 22; FLOT, 21). Thirty-eight (86.4%) patients completed four cycles of preoperative chemotherapy and 32 (74.4%) proceeded to surgery, with 67.4% R0 resections on intent-to-treat analysis (90.1% of the 32 patients who underwent resection). Median overall survival was not reached and median progression-free survival (PFS) was 17.3 months. Compared with the FLO group, the FLOT group showed a trend towards an improved median PFS (21.1 vs 12.0 months; P=0.09), however, associated with increased chemotherapy related toxicity. No perioperative mortality was observed. Postoperative morbidity was observed in 46.9% of patients (FLO, 35.3%; FLOT, 60%).Neoadjuvant FLO or FLOT may offer a reasonable chance of curative surgery in elderly patients with locally advanced resectable gastroesophageal cancer. However, the increase in side effects with the FLOT regimen and postoperative morbidity should be carefully considered when an intensive chemotherapy regimen is planned." @default.
• W2024069318 created "2016-06-24" @default.
• W2024069318 creator A5000610387 @default.
• W2024069318 creator A5003615636 @default.
• W2024069318 creator A5005554580 @default.
• W2024069318 creator A5060553987 @default.
• W2024069318 creator A5066426980 @default.
• W2024069318 creator A5079396046 @default.
• W2024069318 date "2013-01-15" @default.
• W2024069318 modified "2023-10-06" @default.
• W2024069318 title "Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer" @default.
• W2024069318 cites W1579790358 @default.
• W2024069318 cites W1967103434 @default.
• W2024069318 cites W1988439088 @default.
• W2024069318 cites W1991540586 @default.
• W2024069318 cites W2022674159 @default.
• W2024069318 cites W2031034398 @default.
• W2024069318 cites W2046970652 @default.
• W2024069318 cites W2065828539 @default.
• W2024069318 cites W2065982243 @default.
• W2024069318 cites W2079842887 @default.
• W2024069318 cites W2081358132 @default.
• W2024069318 cites W2086692084 @default.
• W2024069318 cites W2094239535 @default.
• W2024069318 cites W2103892569 @default.
• W2024069318 cites W2108661938 @default.
• W2024069318 cites W2114592324 @default.
• W2024069318 cites W2115072149 @default.
• W2024069318 cites W2119557593 @default.
• W2024069318 cites W2122866527 @default.
• W2024069318 cites W2146834306 @default.
• W2024069318 cites W2149415769 @default.
• W2024069318 cites W2150101057 @default.
• W2024069318 cites W2164787924 @default.
• W2024069318 cites W2167595727 @default.
• W2024069318 cites W2167805334 @default.
• W2024069318 cites W2172102043 @default.
• W2024069318 cites W2331849216 @default.
• W2024069318 cites W4255290073 @default.
• W2024069318 doi "https://doi.org/10.1038/bjc.2012.588" @default.
• W2024069318 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3593547" @default.
• W2024069318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23322206" @default.
• W2024069318 hasPublicationYear "2013" @default.
• W2024069318 type Work @default.
• W2024069318 sameAs 2024069318 @default.
• W2024069318 citedByCount "81" @default.
• W2024069318 countsByYear W20240693182014 @default.
• W2024069318 countsByYear W20240693182015 @default.
• W2024069318 countsByYear W20240693182016 @default.
• W2024069318 countsByYear W20240693182017 @default.
• W2024069318 countsByYear W20240693182018 @default.
• W2024069318 countsByYear W20240693182019 @default.
• W2024069318 countsByYear W20240693182020 @default.
• W2024069318 countsByYear W20240693182021 @default.
• W2024069318 countsByYear W20240693182022 @default.
• W2024069318 countsByYear W20240693182023 @default.
• W2024069318 crossrefType "journal-article" @default.
• W2024069318 hasAuthorship W2024069318A5000610387 @default.
• W2024069318 hasAuthorship W2024069318A5003615636 @default.
• W2024069318 hasAuthorship W2024069318A5005554580 @default.
• W2024069318 hasAuthorship W2024069318A5060553987 @default.
• W2024069318 hasAuthorship W2024069318A5066426980 @default.
• W2024069318 hasAuthorship W2024069318A5079396046 @default.
• W2024069318 hasBestOaLocation W20240693181 @default.
• W2024069318 hasConcept C121608353 @default.
• W2024069318 hasConcept C126322002 @default.
• W2024069318 hasConcept C141071460 @default.
• W2024069318 hasConcept C143998085 @default.
• W2024069318 hasConcept C197934379 @default.
• W2024069318 hasConcept C2776694085 @default.
• W2024069318 hasConcept C2778336483 @default.
• W2024069318 hasConcept C2778375690 @default.
• W2024069318 hasConcept C2780456651 @default.
• W2024069318 hasConcept C2780962732 @default.
• W2024069318 hasConcept C2781190966 @default.
• W2024069318 hasConcept C2781413609 @default.
• W2024069318 hasConcept C31174226 @default.
• W2024069318 hasConcept C526805850 @default.
• W2024069318 hasConcept C71924100 @default.
• W2024069318 hasConceptScore W2024069318C121608353 @default.
• W2024069318 hasConceptScore W2024069318C126322002 @default.
• W2024069318 hasConceptScore W2024069318C141071460 @default.
• W2024069318 hasConceptScore W2024069318C143998085 @default.
• W2024069318 hasConceptScore W2024069318C197934379 @default.
• W2024069318 hasConceptScore W2024069318C2776694085 @default.
• W2024069318 hasConceptScore W2024069318C2778336483 @default.
• W2024069318 hasConceptScore W2024069318C2778375690 @default.
• W2024069318 hasConceptScore W2024069318C2780456651 @default.
• W2024069318 hasConceptScore W2024069318C2780962732 @default.
• W2024069318 hasConceptScore W2024069318C2781190966 @default.
• W2024069318 hasConceptScore W2024069318C2781413609 @default.
• W2024069318 hasConceptScore W2024069318C31174226 @default.
• W2024069318 hasConceptScore W2024069318C526805850 @default.
• W2024069318 hasConceptScore W2024069318C71924100 @default.
• W2024069318 hasIssue "3" @default.
• W2024069318 hasLocation W20240693181 @default.
• W2024069318 hasLocation W20240693182 @default.
• W2024069318 hasLocation W20240693183 @default.

• next